Adenovirus-mediated gene transfer into infarcted myocardium: Feasibility, timing, and location of expression

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 10, 1996, Pages 2057-2067

  Leor, Jonathan ^a   Quiñones, Manuel J ^a   Patterson, Michael ^a   Kedes, Larry ^a   Kloner, Robert A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

Adenovirus; Cardiovascular disease; Gene therapy; Myocardial infarction

Indexed keywords

BETA GALACTOSIDASE; EOSIN; HEMATOXYLIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HEALING; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INFLAMMATION; MAMMAL; MONONUCLEAR CELL; MUSCLE CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; TIME; TRANSGENE;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0030271599     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0199     Document Type: Article

References (25)

1. BERKER K, 1988. Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 6: 616-629.
2. COMINELLI F, NAST C, DUCHINI A, LEE M. 1992. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 103: 65-71.
3. FISHBEIN M, MACLEAN D, MAROKO P. 1978. Experimental myocardial infarction in the rat. Am J Pathol 90: 57-70.
4. FRENCH B, MAZUR W, GESKE R, BOLLI R. 1994. Direct in vivo gene transfer into porcine myocardium by direct injection of adenovirus vectors. Circulation 90: 2414-2424.
5. GOMEZ FAM, COATS WS, BAQUE S, ALAM T, GERARD RD, NEWGARD CB. 1992. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem 267: 25129-25134.
6. GUSMAN RJ, LEMARCHAND P, CRYSTAL RG, EPSTEIN SE, FINKEL T. 1993. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 73: 1202-1207.
7. HALE S, KLONER R. 1991. Time course of infiltration and distribution of neutrophils following coronary artery reperfusion in the rat. Cor Art Dis 2: 373-378.
8. HAMMERMAN H, KLONER R, SCHOEN F, BROWN EJ, HALE S, BRAUNWALD E. 1983. Indomethacin induced scar thinning following experimental myocardial infarction. Circulation 67: 1290-1295.
9. HUANG S, ENDO RI, NEMEROW GR. 1995. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 69: 2257-2263.
10. ISNER J, FELDMAN L. 1994. Gene therapy for arterial disease. Lancet 344: 1653-1654.
11. KASS-EISLER A, FALCK-PEDERSEN E, ALVIRA M, RIVERA J, BUTTRICK P, WITTENBERG B, CIPRIANI L, LEINWAND L, 1993. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA 90: 11498-11502.
12. LAZARUS D, SCHEINOWITZ M, SHOU M et al., 1995. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91: 145-153.
13. LEOR J, KLONER R. 1995. An experimental model examining the role of magnesium in the therapy of acute myocardial infarction. Am J Cardiol 75: 1292-1293.
14. LOSORDO D, PICKERING J, TAKESHITA S. et al. 1994. Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation 89: 785-792.
15. MORISHITA R, GIBBONS G, ELLISON-K E, NAKAJIMA M, ZHANG L, KANEDA Y, OGIHARA T, DZAU V. 1993. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proceedings of the National Academy of Sciences, USA. 90: 8474-8478.
16. NABEL E. 1995. Gene Therapy for Cardiovascular Disease. Circulation 91: 541-548.
17. PRENTICE H, KLONER R, LI Y, NEWMAN L, KEDES L. 1993. High level RSV-luceferase expression following direct DNA injection into ischemic/reperfused myocardium. J Am Coll Cardiol 21: 163A.
18. PRENTICE H, KLONER R, SARTORELLI V, BELLOWS S, ALDER K, KEDES L. 1993. Transformation of cardiac fibroblasts into the ischemic heart. (Abstract) Circulation 88 [Suppl. Part 2] I-475.
19. QUINONES M, LEOR J, KLONER R, ITO M, PATTERSON M, WITKE W, KEDES L. 1995. Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication-defective adenovirus. Circulation in press, 1996.
20. RUMYANTSEV P. 1991. Growth and Hyperplasia of Cardiac Muscle Cells. New York, Harwood Academic Press. 79-159.
21. SCHULICK A, NEWMAN K, VIRMANI D. 1995. In vivo gene transfer into injured carotid arteries: optimization and evaluation of acute toxicity. Circulation 91: 2407-2414.
22. UNGER EF, BANAI S, SHOU M, LAZARUS DF, JAKLITSCH MT, SCHEINOWITZ M, CORREA R, KLINGBEIL C, EPSTEIN SE 1994. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. American Journal of Physiology 266: H1588-H1595.
23. WEINTRAUB H, DAVIS R, TAPSCOTT S. et al. 1991. The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage. Science 251: 761-766.
24. WILLIAMS S. 1993. Prospects of gene therapy of ischemic heart diseases. American Journal of Medical Science 306: 129-136.
25. YANG Y, NUNES FA, BERENCSI K, FURTH EE, GONCZEOL E, WILSON JM. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Nat Acad Sci USA. 91: 4407-4411.